683 Capital Management, LLC Arbutus Biopharma Corp Transaction History

683 Capital Management, LLC

  • $1.4 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$3.14 - $4.84 $313,764 - $483,637
-99,925 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$2.76 - $4.97 $275,793 - $496,627
99,925 New
99,925 $355,000
Q1 2020

May 15, 2020
SELL
$1.01 - $3.42 $78,141 - $264,598
-77,368 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$0.87 - $2.89 $67,310 - $223,593
77,368 New
77,368 $215,000

Others Institutions Holding ABUS

# of Institutions
169
Shares Held
101M
Call Options Held
649K
Put Options Held
666K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $511M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email